Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dabigatran in LVAD Patients
NCT02872649Phase 2Terminated
- Start
- Jan 2013
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of dabigatran in thrombosis (2 arms). Primary endpoints: Number of major and minor adverse events due to thromboembolic complications at 1 year, Number of major and minor bleeding events at 1 year and 2 more. Started Jan 2013; status: terminated.
02
Drugs
dabigatran
03
Conditions
thrombosis
Beyond the preview
Go deeper on NCT02872649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02872649.